These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33606428)

  • 1. Effect of Statin Use on Cancer-related Mortality in Nonalcoholic Fatty Liver Disease: A Prospective United States Cohort Study.
    Hajifathalian K; Tafesh Z; Rosenblatt R; Kumar S; Homan EA; Sharaiha RZ; Cohen DE; Brown RS; Fortune BE
    J Clin Gastroenterol; 2022 Feb; 56(2):173-180. PubMed ID: 33606428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals.
    Ng CH; Teng ML; Chew NW; Chan KE; Yong JN; Quek J; Tan DJH; Lim WH; Lee GSJ; Wong J; Kaewdech A; Huang DQ; Wang J; Chan MY; Noureddin M; Siddiqui MS; Sanyal A; Muthiah M
    Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):895-901. PubMed ID: 36036200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Fatty Liver Disease.
    Zou B; Odden MC; Nguyen MH
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):435-444.e6. PubMed ID: 35158055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.
    Athyros VG; Boutari C; Stavropoulos K; Anagnostis P; Imprialos KP; Doumas M; Karagiannis A
    Curr Vasc Pharmacol; 2018; 16(3):246-253. PubMed ID: 28676019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study.
    van den Berg EH; Wolters AAB; Dullaart RPF; Moshage H; Zurakowski D; de Meijer VE; Blokzijl H
    Liver Int; 2019 Jul; 39(7):1343-1354. PubMed ID: 30968536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality.
    Konyn P; Alshuwaykh O; Dennis BB; Cholankeril G; Ahmed A; Kim D
    Clin Gastroenterol Hepatol; 2023 Apr; 21(4):940-948.e2. PubMed ID: 35643414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia.
    Blais P; Lin M; Kramer JR; El-Serag HB; Kanwal F
    Dig Dis Sci; 2016 Jun; 61(6):1714-20. PubMed ID: 26707137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study.
    Ayada I; van Kleef LA; Zhang H; Liu K; Li P; Abozaid YJ; Lavrijsen M; Janssen HLA; van der Laan LJW; Ghanbari M; Peppelenbosch MP; Zheng MH; de Knegt RJ; Pan Q
    EBioMedicine; 2023 Jan; 87():104392. PubMed ID: 36502575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
    Kim D; Kim WR; Kim HJ; Therneau TM
    Hepatology; 2013 Apr; 57(4):1357-65. PubMed ID: 23175136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States.
    Kim D; Wijarnpreecha K; Sandhu KK; Cholankeril G; Ahmed A
    Liver Int; 2021 Aug; 41(8):1832-1840. PubMed ID: 33641244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States.
    Wijarnpreecha K; Scribani M; Kim D; Kim WR
    Liver Int; 2019 Jul; 39(7):1202-1206. PubMed ID: 30697898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study.
    Lee JI; Lee HW; Lee KS; Lee HS; Park JY
    Am J Gastroenterol; 2021 Jan; 116(1):116-124. PubMed ID: 33027082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016.
    Golabi P; Paik JM; Harring M; Younossi E; Kabbara K; Younossi ZM
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2838-2847.e7. PubMed ID: 34929391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
    Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
    Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease.
    Oni ET; Sinha P; Karim A; Martin SS; Blaha MJ; Agatston AS; Blumenthal RS; Meneghelo RS; Conceiçao RD; Santos RD; Nasir K
    Arch Med Res; 2014 Jan; 45(1):52-7. PubMed ID: 24333254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
    Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in statin utilisation in US adults with non-alcoholic fatty liver disease.
    Henson JB; Patel YA; Muir AJ
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1481-1489. PubMed ID: 34653272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
    Ciardullo S; Perseghin G
    Metabolism; 2021 Aug; 121():154752. PubMed ID: 33716004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food Insecurity is Associated With Mortality Among U.S. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis.
    Kardashian A; Dodge JL; Terrault NA
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2790-2799.e4. PubMed ID: 34958747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.